Liquid biopsy: emergence of a new era in personalized cancer care
Appl. cancer res
;
38: 1-17, jan. 30, 2018. tab, ilus
Artigo
em Inglês
| LILACS, Inca
| ID: biblio-910469
ABSTRACT
The most successful treatment for cancer involves identifying druggable, biological markers for targeted therapy. In the clinical setting, surgical removal of tumors is the only procedure for identifying such targetable molecules. Shed from tumor cells, these markers are also present in circulating blood, albeit in very negligible amounts. Liquid biopsy is a procedure performed on a blood sample to look for such circulating cancer markers cells or pieces of nucleic acid from the tumor. The procedure shows promise in revolutionizing personalized cancer treatments. Here we briefly review the technique, characterization, and its utilization in clinics
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Biomarcadores
/
Terapia de Alvo Molecular
/
Ácidos Nucleicos Livres
/
Biópsia Líquida
/
Células Neoplásicas Circulantes
Limite:
Humanos
Idioma:
Inglês
Revista:
Appl. cancer res
Assunto da revista:
Neoplasias
Ano de publicação:
2018
Tipo de documento:
Artigo
País de afiliação:
Índia
Instituição/País de afiliação:
All India Institute of Medical Sciences/BR
/
All India Institute of Medical Sciences/IN
Similares
MEDLINE
...
LILACS
LIS